Enter your terms above and click the 'Search' button.

Showing articles 0 to 12 of 12 Filter Applied: practice guidelines (Click to remove) Efficacy and Tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy Neurol 91:82-90, Kanner, A.M.,et al, 2018 Efficacy and Tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy Neurol 91:74-81, Kanner, A.M.,et al, 2018 Evidence-based Guideline: Treatment of Parenchymal Neurocysticercosis Neurol 80:1424-1429, Baird, R.,et al, 2013 Evidence-based Guideline: Antiepileptic Drug Selection for People with HIV/AIDS Neurol 78:139-145, Birbeck,G.L.,et al, 2012 Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy JAMA 307:922-930, Engel, J.,et al, 2012 Position Statement on the Coverage of Anticonvulsant Drugs for the Treatment of Epilepsy Neurol 68:1249-1250,1245, Liow,K.,et al, 2007 Adult Epilepsy Lancet 367:1087-1100, Duncan,J.S.,et al, 2006 Status Epilepticus: An Evidence Based Guide BMJ 331:673-677, Walker,M., 2005 Efficacy and Tolerability for the New Antiepileptic Drugs I: Treatment of New Onset Epilepsy Neurol 62:1252-1260, French,J.A.,et al, 2004 Efficacy and Tolerability of the New Antiepleptic Drugs II: Treatment of Refractory Epilepsy Neurol 62:1261-1273, French,J.A.,et al, 2004 Practice Advisory:The Use of Felbamate in the Treatment of Patients with Intractable Epilepsy, Report of the quality Standards Subcommittee of the AAN and the American Epilepsy Society Neurol 52:1540-1545, French,J.,et al, 1999 Intravenous Immunoglobulin Treatment of Neurological Disease JNNP 60:359-361, Otten,A.,et al, 1996 Showing articles 0 to 12 of 12